Hallgeir Rui - Publications

Affiliations: 
Uniformed Services University of the Health Sciences, Bethesda, MD 
Area:
Molecular Biology, Oncology, Cell Biology

55 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Talati PG, Gu L, Ellsworth EM, Girondo MA, Trerotola M, Hoang DT, Leiby B, Dagvadorj A, McCue PA, Lallas CD, Trabulsi EJ, Gomella L, Aplin AE, Languino L, Fatatis A, ... Rui H, et al. Jak2-Stat5a/b Signaling Induces Epithelial-to-Mesenchymal Transition and Stem-Like Cell Properties in Prostate Cancer. The American Journal of Pathology. 185: 2505-22. PMID 26362718 DOI: 10.1016/j.ajpath.2015.04.026  0.64
2015 Liao Z, Gu L, Vergalli J, Mariani SA, De Dominici M, Lokareddy RK, Dagvadorj A, Purushottamachar P, McCue PA, Trabulsi E, Lallas CD, Gupta S, Ellsworth E, Blackmon S, Ertel A, ... ... Rui H, et al. Structure-Based Screen Identifies a Potent Small Molecule Inhibitor of Stat5a/b with Therapeutic Potential for Prostate Cancer and Chronic Myeloid Leukemia. Molecular Cancer Therapeutics. PMID 26026053 DOI: 10.1158/1535-7163.MCT-14-0883  0.64
2014 Wilson C, Lin JE, Li P, Snook AE, Gong J, Sato T, Liu C, Girondo MA, Rui H, Hyslop T, Waldman SA. The paracrine hormone for the GUCY2C tumor suppressor, guanylin, is universally lost in colorectal cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 2328-37. PMID 25304930 DOI: 10.1158/1055-9965.EPI-14-0440  0.76
2014 Bhattacharya S, Katlinski KV, Reichert M, Takano S, Brice A, Zhao B, Yu Q, Zheng H, Carbone CJ, Katlinskaya YV, Leu NA, McCorkell KA, Srinivasan S, Girondo M, Rui H, et al. Triggering ubiquitination of IFNAR1 protects tissues from inflammatory injury. Embo Molecular Medicine. 6: 384-97. PMID 24480543 DOI: 10.1002/emmm.201303236  0.76
2014 Yoshida M, Selvan S, McCue PA, DeAngelis T, Baserga R, Fujii A, Rui H, Mastrangelo MJ, Sato T. Expression of insulin-like growth factor-1 receptor in metastatic uveal melanoma and implications for potential autocrine and paracrine tumor cell growth. Pigment Cell & Melanoma Research. 27: 297-308. PMID 24354797 DOI: 10.1111/pcmr.12206  0.76
2013 Li Q, Fu GB, Zheng JT, He J, Niu XB, Chen QD, Yin Y, Qian X, Xu Q, Wang M, Sun AF, Shu Y, Rui H, Liu LZ, Jiang BH. NADPH oxidase subunit p22(phox)-mediated reactive oxygen species contribute to angiogenesis and tumor growth through AKT and ERK1/2 signaling pathways in prostate cancer. Biochimica Et Biophysica Acta. 1833: 3375-85. PMID 24113386 DOI: 10.1016/j.bbamcr.2013.09.018  0.76
2013 Yang N, Liu C, Peck AR, Girondo MA, Yanac AF, Tran TH, Utama FE, Tanaka T, Freydin B, Chervoneva I, Hyslop T, Kovatich AJ, Hooke JA, Shriver CD, Rui H. Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironment. Breast Cancer Research : Bcr. 15: R73. PMID 24004716 DOI: 10.1186/bcr3467  0.76
2013 Chen K, Wu K, Gormley M, Ertel A, Wang J, Zhang W, Zhou J, Disante G, Li Z, Rui H, Quong AA, McMahon SB, Deng H, Lisanti MP, Wang C, et al. Acetylation of the cell-fate factor dachshund determines p53 binding and signaling modules in breast cancer. Oncotarget. 4: 923-35. PMID 23798621  0.76
2013 Sato T, Tran TH, Peck AR, Liu C, Ertel A, Lin J, Neilson LM, Rui H. Global profiling of prolactin-modulated transcripts in breast cancer in vivo. Molecular Cancer. 12: 59. PMID 23758962 DOI: 10.1186/1476-4598-12-59  0.76
2013 Haddad BR, Gu L, Mirtti T, Dagvadorj A, Vogiatzi P, Hoang DT, Bajaj R, Leiby B, Ellsworth E, Blackmon S, Ruiz C, Curtis M, Fortina P, Ertel A, Liu C, ... Rui H, et al. STAT5A/B gene locus undergoes amplification during human prostate cancer progression. The American Journal of Pathology. 182: 2264-75. PMID 23660011 DOI: 10.1016/j.ajpath.2013.02.044  0.76
2013 Chen K, Wu K, Cai S, Zhang W, Zhou J, Wang J, Ertel A, Li Z, Rui H, Quong A, Lisanti MP, Tozeren A, Tanes C, Addya S, Gormley M, et al. Dachshund binds p53 to block the growth of lung adenocarcinoma cells. Cancer Research. 73: 3262-74. PMID 23492369 DOI: 10.1158/0008-5472.CAN-12-3191  0.76
2013 Lin WC, Rajbhandari N, Liu C, Sakamoto K, Zhang Q, Triplett AA, Batra SK, Opavsky R, Felsher DW, DiMaio DJ, Hollingsworth MA, Morris JP, Hebrok M, Witkiewicz AK, Brody JR, ... Rui H, et al. Dormant cancer cells contribute to residual disease in a model of reversible pancreatic cancer. Cancer Research. 73: 1821-30. PMID 23467612 DOI: 10.1158/0008-5472.CAN-12-2067  0.76
2013 Hyslop T, Michael Y, Avery T, Rui H. Population and target considerations for triple-negative breast cancer clinical trials. Biomarkers in Medicine. 7: 11-21. PMID 23387481 DOI: 10.2217/bmm.12.114  0.76
2012 Peck AR, Witkiewicz AK, Liu C, Klimowicz AC, Stringer GA, Pequignot E, Freydin B, Yang N, Ertel A, Tran TH, Girondo MA, Rosenberg AL, Hooke JA, Kovatich AJ, Shriver CD, ... ... Rui H, et al. Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes. Breast Cancer Research : Bcr. 14: R130. PMID 23036105 DOI: 10.1186/bcr3328  0.76
2011 Zhang Q, Sakamoto K, Liu C, Triplett AA, Lin WC, Rui H, Wagner KU. Cyclin D3 compensates for the loss of cyclin D1 during ErbB2-induced mammary tumor initiation and progression. Cancer Research. 71: 7513-24. PMID 22037875 DOI: 10.1158/0008-5472.CAN-11-1783  0.76
2011 Sato T, Neilson LM, Peck AR, Liu C, Tran TH, Witkiewicz A, Hyslop T, Nevalainen MT, Sauter G, Rui H. Signal transducer and activator of transcription-3 and breast cancer prognosis. American Journal of Cancer Research. 1: 347-55. PMID 21776434  0.64
2011 Li D, Zhao Y, Liu C, Chen X, Qi Y, Jiang Y, Zou C, Zhang X, Liu S, Wang X, Zhao D, Sun Q, Zeng Z, Dress A, Lin MC, ... ... Rui H, et al. Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 1722-30. PMID 21350001 DOI: 10.1158/1078-0432.CCR-10-1800  0.76
2011 Michal AM, Peck AR, Tran TH, Liu C, Rimm DL, Rui H, Benovic JL. Differential expression of arrestins is a predictor of breast cancer progression and survival. Breast Cancer Research and Treatment. 130: 791-807. PMID 21318602 DOI: 10.1007/s10549-011-1374-9  0.76
2011 Behling KC, Tang A, Freydin B, Chervoneva I, Kadakia S, Schwartz GF, Rui H, Witkiewicz AK. Increased SIAH expression predicts ductal carcinoma in situ (DCIS) progression to invasive carcinoma. Breast Cancer Research and Treatment. 129: 717-24. PMID 21088888 DOI: 10.1007/s10549-010-1254-8  0.76
2010 Varghese B, Swaminathan G, Plotnikov A, Tzimas C, Yang N, Rui H, Fuchs SY. Prolactin inhibits activity of pyruvate kinase M2 to stimulate cell proliferation. Molecular Endocrinology (Baltimore, Md.). 24: 2356-65. PMID 20962042 DOI: 10.1210/me.2010-0219  0.76
2010 Johnson KJ, Peck AR, Liu C, Tran TH, Utama FE, Sjolund AB, Schaber JD, Witkiewicz AK, Rui H. PTP1B suppresses prolactin activation of Stat5 in breast cancer cells. The American Journal of Pathology. 177: 2971-83. PMID 20952588 DOI: 10.2353/ajpath.2010.090399  0.76
2010 Dagvadorj A, Tan SH, Liao Z, Xie J, Nurmi M, Alanen K, Rui H, Mirtti T, Nevalainen MT. N-terminal truncation of Stat5a/b circumvents PIAS3-mediated transcriptional inhibition of Stat5 in prostate cancer cells. The International Journal of Biochemistry & Cell Biology. 42: 2037-46. PMID 20854925 DOI: 10.1016/j.biocel.2010.09.008  0.64
2010 Richards NG, Rittenhouse DW, Freydin B, Cozzitorto JA, Grenda D, Rui H, Gonye G, Kennedy EP, Yeo CJ, Brody JR, Witkiewicz AK. HuR status is a powerful marker for prognosis and response to gemcitabine-based chemotherapy for resected pancreatic ductal adenocarcinoma patients. Annals of Surgery. 252: 499-505; discussion . PMID 20739850 DOI: 10.1097/SLA.0b013e3181f1fd44  0.76
2010 Tran TH, Lin J, Sjolund AB, Utama FE, Rui H. Protocol for constructing tissue arrays by cutting edge matrix assembly. Methods in Molecular Biology (Clifton, N.J.). 664: 45-52. PMID 20690051 DOI: 10.1007/978-1-60761-806-5_5  0.76
2010 Witkiewicz AK, Freydin B, Chervoneva I, Potoczek M, Rizzo W, Rui H, Brody JR, Schwartz GF, Lisanti MP. Stromal CD10 and SPARC expression in ductal carcinoma in situ (DCIS) patients predicts disease recurrence. Cancer Biology & Therapy. 10: 391-6. PMID 20574156 DOI: 10.4161/cbt.10.4.12449  0.76
2010 Tran TH, Utama FE, Lin J, Yang N, Sjolund AB, Ryder A, Johnson KJ, Neilson LM, Liu C, Brill KL, Rosenberg AL, Witkiewicz AK, Rui H. Prolactin inhibits BCL6 expression in breast cancer through a Stat5a-dependent mechanism. Cancer Research. 70: 1711-21. PMID 20124477 DOI: 10.1158/0008-5472.CAN-09-2314  0.76
2009 Nagy ZS, LeBaron MJ, Ross JA, Mitra A, Rui H, Kirken RA. STAT5 regulation of BCL10 parallels constitutive NFkappaB activation in lymphoid tumor cells. Molecular Cancer. 8: 67. PMID 19709433 DOI: 10.1186/1476-4598-8-67  0.76
2009 Comstock CE, Augello MA, Benito RP, Karch J, Tran TH, Utama FE, Tindall EA, Wang Y, Burd CJ, Groh EM, Hoang HN, Giles GG, Severi G, Hayes VM, Henderson BE, ... ... Rui H, et al. Cyclin D1 splice variants: polymorphism, risk, and isoform-specific regulation in prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 5338-49. PMID 19706803 DOI: 10.1158/1078-0432.CCR-08-2865  0.76
2009 Arendt LM, Evans LC, Rugowski DE, Garcia-Barchino MJ, Rui H, Schuler LA. Ovarian hormones are not required for PRL-induced mammary tumorigenesis, but estrogen enhances neoplastic processes. The Journal of Endocrinology. 203: 99-110. PMID 19635758 DOI: 10.1677/JOE-09-0221  0.76
2009 Popov VM, Zhou J, Shirley LA, Quong J, Yeow WS, Wright JA, Wu K, Rui H, Vadlamudi RK, Jiang J, Kumar R, Wang C, Pestell RG. The cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signaling. Cancer Research. 69: 5752-60. PMID 19605405 DOI: 10.1158/0008-5472.CAN-08-3992  0.76
2009 Mercier I, Casimiro MC, Zhou J, Wang C, Plymire C, Bryant KG, Daumer KM, Sotgia F, Bonuccelli G, Witkiewicz AK, Lin J, Tran TH, Milliman J, Frank PG, Jasmin JF, ... Rui H, et al. Genetic ablation of caveolin-1 drives estrogen-hypersensitivity and the development of DCIS-like mammary lesions. The American Journal of Pathology. 174: 1172-90. PMID 19342371 DOI: 10.2353/ajpath.2009.080882  0.76
2009 Sotgia F, Casimiro MC, Bonuccelli G, Liu M, Whitaker-Menezes D, Er O, Daumer KM, Mercier I, Witkiewicz AK, Minetti C, Capozza F, Gormley M, Quong AA, Rui H, Frank PG, et al. Loss of caveolin-3 induces a lactogenic microenvironment that is protective against mammary tumor formation. The American Journal of Pathology. 174: 613-29. PMID 19164602 DOI: 10.2353/ajpath.2009.080653  0.76
2009 Utama FE, Tran TH, Ryder A, LeBaron MJ, Parlow AF, Rui H. Insensitivity of human prolactin receptors to nonhuman prolactins: relevance for experimental modeling of prolactin receptor-expressing human cells. Endocrinology. 150: 1782-90. PMID 19022890 DOI: 10.1210/en.2008-1057  0.76
2008 Lindsay J, Jiao X, Sakamaki T, Casimiro MC, Shirley LA, Tran TH, Ju X, Liu M, Li Z, Wang C, Katiyar S, Rao M, Allen KG, Glazer RI, Ge C, ... ... Rui H, et al. ErbB2 induces Notch1 activity and function in breast cancer cells. Clinical and Translational Science. 1: 107-15. PMID 20443831 DOI: 10.1111/j.1752-8062.2008.00041.x  0.76
2008 Wang Y, Dean JL, Millar EK, Tran TH, McNeil CM, Burd CJ, Henshall SM, Utama FE, Witkiewicz A, Rui H, Sutherland RL, Knudsen KE, Knudsen ES. Cyclin D1b is aberrantly regulated in response to therapeutic challenge and promotes resistance to estrogen antagonists. Cancer Research. 68: 5628-38. PMID 18632615 DOI: 10.1158/0008-5472.CAN-07-3170  0.76
2007 Neilson LM, Zhu J, Xie J, Malabarba MG, Sakamoto K, Wagner KU, Kirken RA, Rui H. Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathways. Molecular Endocrinology (Baltimore, Md.). 21: 2218-32. PMID 17550976 DOI: 10.1210/me.2007-0173  0.64
2007 Dalmizrak O, Wu A, Chen J, Sun H, Utama FE, Zambelli D, Tran TH, Rui H, Baserga R. Insulin receptor substrate-1 regulates the transformed phenotype of BT-20 human mammary cancer cells. Cancer Research. 67: 2124-30. PMID 17332342 DOI: 10.1158/0008-5472.CAN-06-3954  0.76
2007 LeBaron MJ, Ahonen TJ, Nevalainen MT, Rui H. In vivo response-based identification of direct hormone target cell populations using high-density tissue arrays. Endocrinology. 148: 989-1008. PMID 17138649 DOI: 10.1210/en.2006-1219  0.76
2006 Sotgia F, Rui H, Bonuccelli G, Mercier I, Pestell RG, Lisanti MP. Caveolin-1, mammary stem cells, and estrogen-dependent breast cancers. Cancer Research. 66: 10647-51. PMID 17108100 DOI: 10.1158/0008-5472.CAN-06-2805  0.76
2006 Nagy ZS, Rui H, Stepkowski SM, Karras J, Kirken RA. A preferential role for STAT5, not constitutively active STAT3, in promoting survival of a human lymphoid tumor. Journal of Immunology (Baltimore, Md. : 1950). 177: 5032-40. PMID 17015686  0.76
2006 Utama FE, LeBaron MJ, Neilson LM, Sultan AS, Parlow AF, Wagner KU, Rui H. Human prolactin receptors are insensitive to mouse prolactin: implications for xenotransplant modeling of human breast cancer in mice. The Journal of Endocrinology. 188: 589-601. PMID 16522738 DOI: 10.1677/joe.1.06560  0.76
2006 Selliah N, Zhang M, DeSimone D, Kim H, Brunner M, Ittenbach RF, Rui H, Cron RQ, Finkel TH. The gammac-cytokine regulated transcription factor, STAT5, increases HIV-1 production in primary CD4 T cells. Virology. 344: 283-91. PMID 16289657 DOI: 10.1016/j.virol.2005.09.063  0.76
2005 Rui H, LeBaron MJ. Creating tissue microarrays by cutting-edge matrix assembly. Expert Review of Medical Devices. 2: 673-80. PMID 16293094 DOI: 10.1586/17434440.2.6.673  0.76
2005 LeBaron MJ, Crismon HR, Utama FE, Neilson LM, Sultan AS, Johnson KJ, Andersson EC, Rui H. Ultrahigh density microarrays of solid samples. Nature Methods. 2: 511-3. PMID 15973421 DOI: 10.1038/nmeth772  0.76
2005 LeBaron MJ, Xie J, Rui H. Evaluation of genome-wide chromatin library of Stat5 binding sites in human breast cancer. Molecular Cancer. 4: 6. PMID 15686596 DOI: 10.1186/1476-4598-4-6  0.76
2005 Sultan AS, Xie J, LeBaron MJ, Ealley EL, Nevalainen MT, Rui H. Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells. Oncogene. 24: 746-60. PMID 15592524 DOI: 10.1038/sj.onc.1208203  0.76
2004 Wagner KU, Krempler A, Triplett AA, Qi Y, George NM, Zhu J, Rui H. Impaired alveologenesis and maintenance of secretory mammary epithelial cells in Jak2 conditional knockout mice Molecular and Cellular Biology. 24: 5510-5520. PMID 15169911 DOI: 10.1128/MCB.24.12.5510-5520.2004  0.76
2004 Nevalainen MT, Xie J, Torhorst J, Bubendorf L, Haas P, Kononen J, Sauter G, Rui H. Signal transducer and activator of transcription-5 activation and breast cancer prognosis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 2053-60. PMID 15169792 DOI: 10.1200/JCO.2004.11.046  0.64
2003 Ahonen TJ, Xie J, LeBaron MJ, Zhu J, Nurmi M, Alanen K, Rui H, Nevalainen MT. Inhibition of transcription factor Stat5 induces cell death of human prostate cancer cells. The Journal of Biological Chemistry. 278: 27287-92. PMID 12719422 DOI: 10.1074/jbc.M304307200  0.76
2002 Ahonen TJ, Ha Rko Nen PL, Rui H, Nevalainen MT. PRL Signal Transduction in the Epithelial Compartment of Rat Prostate Maintained as Long-Term Organ Cultures in Vitro. Endocrinology. 143: 228-238. PMID 28201625 DOI: 10.1210/endo.143.1.8576  0.64
2002 Nevalainen MT, Xie J, Bubendorf L, Wagner KU, Rui H. Basal activation of transcription factor signal transducer and activator of transcription (Stat5) in nonpregnant mouse and human breast epithelium. Molecular Endocrinology (Baltimore, Md.). 16: 1108-24. PMID 11981045 DOI: 10.1210/mend.16.5.0839  0.64
2002 Xie J, LeBaron MJ, Nevalainen MT, Rui H. Role of tyrosine kinase Jak2 in prolactin-induced differentiation and growth of mammary epithelial cells. The Journal of Biological Chemistry. 277: 14020-30. PMID 11821424 DOI: 10.1074/jbc.M112399200  0.76
2002 Ahonen TJ, Härkönen PL, Rui H, Nevalainen MT. PRL signal transduction in the epithelial compartment of rat prostate maintained as long-term organ cultures in vitro. Endocrinology. 143: 228-38. PMID 11751614 DOI: 10.1210/endo.143.1.8576  0.64
2001 Yamashita H, Nevalainen MT, Xu J, LeBaron MJ, Wagner KU, Erwin RA, Harmon JM, Hennighausen L, Kirken RA, Rui H. Role of serine phosphorylation of Stat5a in prolactin-stimulated β-casein gene expression Molecular and Cellular Endocrinology. 183: 151-163. PMID 11604235 DOI: 10.1016/S0303-7207(01)00546-9  0.76
1999 Ahonen TJ, Ha Rko Nen PL, Laine J, Rui H, Martikainen PM, Nevalainen MT. Prolactin Is a Survival Factor for Androgen-Deprived Rat Dorsal and Lateral Prostate Epithelium in Organ Culture1. Endocrinology. 140: 5412-5421. PMID 28200565 DOI: 10.1210/endo.140.11.7090  0.64
Show low-probability matches.